<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 25 Aug 2026 01:27:55 -0400--><rss version="2.0">
    <channel>
        <title>FibroBiologics, Inc. (FBLG) Press Releases</title>
        <link>https://ir.fibrobiologics.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_14a954ff2903678ce9699bf59a0e1fd9/fibrobiologics/files/theme/images/logo-sm.png</url>
                <title>FibroBiologics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[FibroBiologics Appoints Leigh Steinberg to Board of Directors]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/134/fibrobiologics-appoints-leigh-steinberg-to-board-of-directors</link>
                <pubDate>Mon, 24 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/134/fibrobiologics-appoints-leigh-steinberg-to-board-of-directors</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/133/fibrobiologics-announces-australian-patent-accepted-for-cannabidiol-adjuvant-therapy-for-the-treatment-of-degenerative-disc-disease</link>
                <pubDate>Thu, 20 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/133/fibrobiologics-announces-australian-patent-accepted-for-cannabidiol-adjuvant-therapy-for-the-treatment-of-degenerative-disc-disease</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/132/fibrobiologics-announces-chondrocyte-spheroids-demonstrate-cartilage-repair-in-preclinical-study-of-degenerative-joints</link>
                <pubDate>Tue, 18 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/132/fibrobiologics-announces-chondrocyte-spheroids-demonstrate-cartilage-repair-in-preclinical-study-of-degenerative-joints</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/131/fibrobiologics-granted-u-s-patent-covering-the-use-of-fibroblasts-to-enhance-survival-and-function-of-transplanted-insulin-producing-islets</link>
                <pubDate>Tue, 11 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/131/fibrobiologics-granted-u-s-patent-covering-the-use-of-fibroblasts-to-enhance-survival-and-function-of-transplanted-insulin-producing-islets</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/130/fibrobiologics-granted-european-patent-covering-gene-therapy-for-the-regeneration-of-cartilage</link>
                <pubDate>Wed, 05 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/130/fibrobiologics-granted-european-patent-covering-gene-therapy-for-the-regeneration-of-cartilage</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/129/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candidate</link>
                <pubDate>Fri, 31 Jul 26 17:34:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/129/fibrobiologics-reports-second-quarter-2026-financial-results-progresses-clinical-trial-evaluating-lead-wound-care-candidate</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/128/fibrobiologics-appoints-kathleen-kate-rubins-ph-d-to-board-of-directors</link>
                <pubDate>Thu, 09 Jul 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/128/fibrobiologics-appoints-kathleen-kate-rubins-ph-d-to-board-of-directors</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/127/fibrobiologics-completes-manufacturing-of-third-batch-of-cywc628-drug-product-for-phase-12-diabetic-foot-ulcer-clinical-trial</link>
                <pubDate>Tue, 07 Jul 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/127/fibrobiologics-completes-manufacturing-of-third-batch-of-cywc628-drug-product-for-phase-12-diabetic-foot-ulcer-clinical-trial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/126/fibrobiologics-to-participate-in-fireside-chat-at-h-c-wainwright-4th-annual-cell-therapy-virtual-conference</link>
                <pubDate>Tue, 30 Jun 26 08:30:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/126/fibrobiologics-to-participate-in-fireside-chat-at-h-c-wainwright-4th-annual-cell-therapy-virtual-conference</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.fibrobiologics.com/news-events/press-releases/detail/125/fibrobiologics-announces-closing-of-up-to-9-0-million-private-placement-priced-at-the-market-under-nasdaq-rules</link>
                <pubDate>Mon, 29 Jun 26 16:01:00 -0400</pubDate>
                <guid>https://ir.fibrobiologics.com/news-events/press-releases/detail/125/fibrobiologics-announces-closing-of-up-to-9-0-million-private-placement-priced-at-the-market-under-nasdaq-rules</guid>
                                                                            </item>
            </channel>
</rss>